Welcome to ShortCuts, yet another new feature of Clinical Correlations. Every week we will post what we feelare the 5 most interesting articles from the news and literature with links. We’re not attempting to digest any of this for you or to be …
Month: March 2007
Clinical Correlations
More Breaking News for the Glitazones…
March 15, 2007
Coming right on the heels of the recent warning from the FDA about the risk of fractures and Rosiglitazone, the FDA announced on March 9th that pioglitazone (Actos) has also been linked to an increased occurrence of arm, hand, and foot fractures among …
When Should You Order a Serum Fructosamine Level for a Diabetic Patient?
March 14, 2007
Commentary By: Christopher Johnson, MSIV and Glenn Matfin, MD Clinical Associate Professor of Medicine, Divsion of Endocrinology
When was the last time you had a diabetic patient in clinic whose hemoglobin A1C was elevated, prompting you to modify their diabetic regimen? …
The Most Intriguing Medical Facts of 2006
March 13, 2007
Although it’s almost spring and the spate of “best of the year” lists are now long gone, I recently came across this list from the AMA news. It’s a summary of their most intriguing facts of 2006. It’s fascinating stuff. Some of the …
Does the Overuse of Macrolides Lead to Antibiotic Resistance?
March 12, 2007
Commentary By: Danise Schiliro, PGY-3
Although intuitively we always worry about creating drug resistance when using antibiotics, there is a surprising lack of well done studies that show a clear causal effect of antibiotic use on the development of subsequent drug resistance. A …
How Do You Approach A Patient with a Non-Ischemic Cardiomyopathy
March 7, 2007
A 26 year old woman developed uncontrolled hypertension peripartum 5 years prior to this presentation After diagnosis she was intermittently compliant with her medication although remained asymptomatic. She now presents with new onset congestive heart failure. On admission, she was in …
More Breaking News: Rosiglitazone Linked to Fractures
March 6, 2007
Commentary By: Cara Litvin PGY-3
The FDA recently informed physicians of a report issued by GlaxoSmithKline acknowledging that Avandia (rosiglitazone) has been linked to increased fractures in females (1). The report stems from a review of the safety data from ADOPT (A Diabetes …